BROWSE·page 259 of 794

Browse EX-10 agreements

9,528 total material contract exhibits.


AT THE MARKET OFFERING AGREEMENT

July 17, 2026

H.C. Wainwright & Co., LLC

430 Park Avenue

New York, New York 10022

Ladies and Gentlemen:

Amesite Inc., a corporation organized under the laws of Delaware (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (the “Manager”) as follows:

1. Definitions. The terms that follow, when used in this Agreement and any Terms Agreement, shall have the meanings indicated.

Accountants” shall have the meaning ascribed to such term in Section 4(m).

Act” shall mean the Securities Act of 1933, as amended, and the rules and regulations of the Commission promulgated thereunder.

Action” shall have the meaning ascribed to such term in Section 3(p).

Affiliate” shall have the meaning ascribed to such term in Section 3(o).

Applicable Time” shall mean, with respect to any Shares, the time of sale of such Shares pursuant to this Agreement or any relevant Terms Agreement.

Base Prospectus” shall mean the base prospectus contained in the Registration Statement at the Execution Time.

EX-10.1·8-K·CIK 1807166·ACC 0001213900-26-079637·Filed Jul 20, 2026, 16:30 ET

** **

REGISTRATION RIGHTS AGREEMENT

This Registration Rights Agreement (this “Agreement”) is entered into effective as July 16, 2026 (the “Execution Date”), by and between Grande Group Limited, a business company incorporated under the laws of the British Virgin Islands (the “Company”), and White Lion Capital, LLC, a Nevada limited liability company (the “Investor”).

RECITALS

A. WHEREAS, the Company may issue and sell to the Investor, from time to time, and the Investor shall purchase from the Company, up to $40,000,000 in aggregate gross purchase price of newly issued Ordinary Shares; and

EX-10.2·6-K·CIK 2027722·ACC 0001213900-26-079639·Filed Jul 20, 2026, 16:30 ET

ORDINARY SHARE PURCHASE AGREEMENT

This Ordinary Share Purchase Agreement (this “Agreement”) is entered into effective as July 16, 2026 (the “Execution Date”), by and between Grande Group Limited, a business company incorporated under the laws of the British Virgin Islands (the “Company”), and White Lion Capital, LLC, a Nevada limited liability company (the “Investor”).

WHEREAS, the parties desire that, upon the terms and subject to the conditions and limitations set forth herein, during the Commitment Period (as defined herein), the Company may issue and sell to the Investor, from time to time as provided herein, and the Investor shall purchase from the Company, up to $40,000,000 in aggregate gross purchase price of newly issued Ordinary Shares (as defined herein);

** **

EX-10.1·6-K·CIK 2027722·ACC 0001213900-26-079639·Filed Jul 20, 2026, 16:30 ET

AT-THE-MARKET ISSUANCE SALES AGREEMENT

July 20, 2026

Aegis Capital Corp.

1345 Avenue of the Americas, 27th Floor
New York, NY 10105

Ladies and Gentlemen:

Sunshine Biopharma Inc., a Colorado corporation (the “Company”), confirms its agreement (this “Agreement”) with Aegis Capital Corp. (“Sales Agent”), as follows:

| | |

EX-10.1·8-K·CIK 1402328·ACC 0001683168-26-005656·Filed Jul 20, 2026, 16:27 ET

EX-10.3

TCGX Acquisition Corp.

**REGISTRATION RIGHTS AGREEMENT **

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of    , 2026, is made and entered into by and among TCGX Acquisition Corp., a Cayman Islands exempted company (the “Company”), TCGX Sponsor, LLC, a Delaware limited liability company (the “Sponsor”), Jefferies LLC (“Jefferies”), TCG Crossover Fund III, LP, a Delaware limited partnership (the “Fund”),*** and each of the undersigned parties listed on the signature page hereto under “Holders” (each such party, together with the Sponsor, Jefferies and the Fund and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2* of this Agreement, a “Holder” and collectively the “Holders”).

**RECITALS **

EX-10.3·S-1·CIK 2137965·ACC 0001193125-26-308950·Filed Jul 20, 2026, 16:20 ET

EX-10.4

TCGX Acquisition Corp.

**INDEMNITY AGREEMENT **

THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of [•], 2026, by and between TCGX Acquisition Corp., a Cayman Islands exempted company (the “Company”), and [•] (“Indemnitee”).

WHEREAS, highly competent persons have become more reluctant to serve publicly-held companies as directors, officers or in other capacities unless they are provided with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising out of their service to and activities on behalf of such companies;

EX-10.4·S-1·CIK 2137965·ACC 0001193125-26-308950·Filed Jul 20, 2026, 16:20 ET

EX-10.8

TCGX Acquisition Corp.

**PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT **

THIS PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT, dated as of    , 2026, (as it may from time to time be amended, this “Agreement”), is entered into by and between TCGX Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Jefferies LLC, the representative of the underwriters of this offering (“Jefferies”), a Delaware LLC, (the “Purchaser”).

WHEREAS, the Company intends to consummate an initial public offering (the “Public Offering”) of shares of the Company’s Class A Ordinary Shares, par value $0.0001 per share (the “Shares”). The Purchaser has agreed to purchase an aggregate of 75,000 Shares (or 86,250 in the aggregate if the over-allotment option in connection with the Initial Public Offering is exercised in full) (the “Private Placement Shares”).

EX-10.8·S-1·CIK 2137965·ACC 0001193125-26-308950·Filed Jul 20, 2026, 16:20 ET

EX-10.5

TCGX Acquisition Corp.

THIS PROMISSORY NOTE (THIS “NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

**PROMISSORY NOTE **

Principal Amount: Up to $300,000 Dated as of June 3, 2026

EX-10.5·S-1·CIK 2137965·ACC 0001193125-26-308950·Filed Jul 20, 2026, 16:20 ET

EX-10.9

TCGX Acquisition Corp.

***FORWARD PURCHASE AGREEMENT ***

This Forward Purchase Agreement (this “Agreement”) is entered into as of    , 2026, by and between TCGX Acquisition Corp., an exempted company under the laws of the Cayman Islands (the “Company”), and TCG Crossover Fund III, LP, a Delaware limited partnership (the “Purchaser”).

WHEREAS, the Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”);

WHEREAS, the Company has filed with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement on Form S-1 (the “Registration Statement”) for its initial public offering (“IPO”) of 7,500,000 Class A ordinary shares, par value $0.0001 per share (the “Class*** A Shares*”, and the Class A Shares sold in the IPO, the “Public Shares”) (or 8,625,000 Class A Shares if the underwriters’ over-allotment option (the “IPO Option”) is exercised in full) at a price of $10.00 per Public Share;

EX-10.9·S-1·CIK 2137965·ACC 0001193125-26-308950·Filed Jul 20, 2026, 16:20 ET

EX-10.6

TCGX Acquisition Corp.

**TCGX Acquisition Corp. **

245 Lytton Ave., Suite 350

Palo Alto, California 94301

June 3, 2026

**TCGX Sponsor, LLC **

245 Lytton Ave., Suite 350

Palo Alto, California 94301

RE: Securities Subscription Agreement

Ladies and Gentlemen:

TCGX Acquisition Corp., a Cayman Islands exempted company (the “Company”), is pleased to accept the offer TCGX Sponsor, LLC, a Delaware limited liability company (the “Subscriber” or “you”), has made to subscribe for 2,156,250 Class B ordinary shares of the Company (the “Shares”), $0.0001 par value per share (the “Class B Ordinary Shares”), up to 281,250 of which are subject to complete or partial forfeiture by you if the underwriters of the Company’s initial public offering (“IPO”) of Class A ordinary shares of the Company, $0.0001 par value per share (the “Class A Ordinary Shares”), do not fully exercise their over-allotment option (the “Over-allotment Option”). For the purposes of this Agreement, references t

EX-10.6·S-1·CIK 2137965·ACC 0001193125-26-308950·Filed Jul 20, 2026, 16:20 ET

EX-10.7

TCGX Acquisition Corp.

**PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT **

THIS PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT, dated as of    , 2026, (as it may from time to time be amended, this “Agreement”), is entered into by and between TCGX Acquisition Corp., a Cayman Islands exempted company (the “Company”), and TCGX Sponsor, LLC, a Delaware limited liability company (the “Purchaser”).

WHEREAS, the Company intends to consummate an initial public offering (the “Public Offering”) of shares of the Company’s Class A Ordinary Shares, par value $0.0001 per share (the “Shares”). The Purchaser has agreed to purchase an aggregate of 425,000 Shares (or 436,250 in the aggregate if the over-allotment option in connection with the Public Offering is exercised in full) (the “Private Placement Shares”).

NOW THEREFORE, in consideration of the mutual promises contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:

EX-10.7·S-1·CIK 2137965·ACC 0001193125-26-308950·Filed Jul 20, 2026, 16:20 ET

EX-10.1

TCGX Acquisition Corp.

, 2026

TCGX Acquisition Corp.

245 Lytton Ave., Suite 350

Palo Alto, California 94301

Re: Initial Public Offering

Ladies and Gentlemen:

This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between TCGX Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Jefferies LLC, as representative (the “Representative”) of the several underwriters (each, an “Underwriter” and collectively, the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”), of up to 8,625,000 of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Class********* A Ordinary Shares***”) (including up to 1,125,000 Class A Ordinary Shares that may be purchased to cover over-allotments, if any). The Class A Ordinary Shares will be sold in the Public Offering pursuant to a registration statement on Form S-1 and p

EX-10.1·S-1·CIK 2137965·ACC 0001193125-26-308950·Filed Jul 20, 2026, 16:20 ET